Secondary pneumothorax as a potential marker of apatinib efficacy in osteosarcoma: a multicenter analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Secondary pneumothorax as a potential marker of apatinib efficacy in osteosarcoma: a multicenter analysis

Published:2020-11-12 Issue:1 Volume:32 Page:82-87
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Tian Zhichao,Liu Huimin,Zhao Yao,Wang Xiaofeng,Ren Hongyan,Zhang Fan,Li Po,Zhang Peng,Wang Jiaqiang,Yao Weitao

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference33 articles.

1. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons.;Mirabello;Int J Cancer,2009

2. Variability in the reported management of pulmonary metastases in osteosarcoma.;Bhattasali;Cancer Med,2015

3. Current and future therapeutic approaches for osteosarcoma.;Harrison;Expert Rev Anticancer Ther,2018

4. Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial.;Grignani;Lancet Oncol,2015

5. Apatinib for Advanced Osteosarcoma after failure of standard multimodal therapy: an open label phase ii clinical trial.;Xie;Oncologist,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osimertinib-induced severe bilateral pneumothorax: A case report;Medicine;2024-01-19

2. Recent advances and pathological mechanisms in photodynamic and sonodynamic therapy in the treatment of bone tumors (Review);Oncology Reports;2023-09-25

3. Tyrosine kinase inhibitor therapy in pediatric sarcoma: Prognostic implications of pulmonary metastatic cavitation;Pediatric Blood & Cancer;2023-08-14

4. Secondary Spontaneous Pneumothorax in Malignancy: A Rare Entity;Journal of Marine Medical Society;2023-07-24

5. A Cohort Study to Evaluate the Efficacy and Value of CT Perfusion Imaging in Patients with Metastatic Osteosarcoma after Chemotherapy;Computational and Mathematical Methods in Medicine;2022-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3